Gene therapy for inherited retinal dystrophiesies;Terapia gênica em distrofias hereditárias de retina

Arquivos Brasileiros de Oftalmologia

Volumn 72, Issue 4, 2009, Pages 560-566

  Côco, Monique ^a   Han, Sang Won ^a   Sallum, Juliana Maria Ferraz ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Eye diseases, hereditary; Gene therapy; Gene transfer techniques; Genetic vectors; Retina

Indexed keywords

EID: 74049151516     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/s0004-27492009000400026     Document Type: Article

References (39)

1. Morales MM. Terapias avançadas: célula-tronco, terapia gênica e nanotecnologia aplicada à saúde. In: Sang WH. Introdução. História da terapia gênica, estado da arte, técnicas e ética. São Paulo: Atheneu; 2007. p.105-25.
2. Morales MM. Terapias Avançadas-Célula-tronco, terapia gênica e nanotecnologia aplicada à saúde. In: Bryan E. Strauss. Vetores para terapia gênica. Vírus, plasmídeos e outros métodos. São Paulo: Atheneu; 2007. p.126-48.
3. Ali RR, Reichel MB, Hunt DM, Bhattacharya SS. Gene therapy for inherited retinal degeneration. Br J Ophtalmol. 1997:81(9):795-801.
4. Wright AF. Gene therapy for the eye. Br J Ophthalmol. 1997:81(8):620-3.
5. Nardi NB, Teixeira LA, Silva EF. Terapia gênica. Cienc Saúde Coletiva. 2002; 7(1):109-16.
6. Lehninger AL, Nelson DL, Cox MM. Princípios de Bioquímica. São Paulo: Sarvier; 2002. p.975.
7. Takahashi M, Miyoshi H, Verma IM, Gage FH. Rescue from photoreceptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer. J Virol. 1999;73(9):7812-6.
8. Bainbridge JW, Stephens C, Parsley K, Demaison C, Halfyard A, Thrasher AJ, et al. In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector: efficient long-term transduction of corneal endothelium and retinal pigment epithelium. Gene Ther. 2001;8(21):1665-8.
9. Li T, Adamian M, Roof DJ, Berson EL, Dryja TP, Roessler BJ, Davidson BL. In vivo transfer of a reporter gene to the retina mediated by an adenoviral vector. Invest Ophthalmol Vis Sci. 1994;35(5):2543-9.
10. Bennett J, Wilson J, Sun D, Forbes B, Maguire A. Adenovirus vector-mediated in vivo gene transfer into adult murine retina. Invest Ophthalmol Vis Sci. 1994; 35(5):2535-42.
11. Ali RR, Reichel MB, Thrasher AJ, Levinsky RJ, Kinnon C, Kanuga N, et al. Gene transfer into the mouse retina mediated by an adeno-associated viral vector. Human Mol Genet. 1996;5(5):591-4.
12. Jomary C, Vicent KA, Grist J, Neal MJ, Jones SE. Rescue of photoreceptor function by AAV-mediated gene transfer in a mouse model of inherited retinal degeneration. Gene Therapy. 1997;4(7):683-90.
13. Hodgson CP, Solaiman R. Virosomes: cationic liposomes enhance retroviral transduction. Nat Biotechnol. 1996;14(3):339-42.
14. Cai X., Conley S, Naash M. Nanoparticle applications in ocular gene therapy. Vision Res. 2008;48(3):319-24.
15. Farjo R, Skaggs J, Quiambao AB, Cooper MJ, Naash MI. Efficient non-viral ocular gene transfer with compacted DNA nanoparticles. PLoS ONE. 2006; Dec 20;1:e38.
16. Chong NH, Bird AC. Management of inherited outer retinal dystrophies: present and future. Br J Ophtalmol. 1999:83(1):120-2.
17. Faktorovich EG, Steinberg RH, Yasumura D, Matthes MT, LaVail MM. Photoreceptor degeneration in inherited retinal dystrophy delayed by basic fibroblast growth factor. Nature. 1990;347(6288):83-6.
18. Borhani H, Peyman GA, Rahimy MH, Beuerman RW. Vitreoretinal toxicity of basic fibroblast growth factor. Int Ophthalmol. 1993;17(4):195-9.
19. Cayouette M, Behn D, Sendtner M, Lachapelle P, Gravel C. Intraocular gene transfer of ciliary neurotrophic factor prevents death and increases responsiveness of rod photoreceptors in the retinal degeneration slow mouse. J Neurosci. 1998; 18(22):9282-93.
20. Tao W, Wen R, Goddard MB, Sherman SD, O'Rourke PJ, Stabila PF, et al. Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2002;43(10): 3292-8.
21. Gal A, Apfeistedt-Sylia E, Janecke AR, Zrennert E. Rhodopsin mutations in inherited retinal dystrophies and dysfunctions. Prog Retin Eye Res. 1997;16(1): 51-79.
22. Unonius N, Farah ME, Sallum JM. Classificação diagnóstica dos portadores de doenças degenerativas de retina, integrantes dos grupos Retina São Paulo e Retina Vale do Paraíba. Arq Bras Oftalmol. 2003;66(5):443-8.
23. Bennett J, Maguire AM. Gene therapy for ocular disease. Mol Ther. 2000; 1(6):501-6.
24. O'Reilly M, Millington-Wards S, Palfi A, Chadderton N, Cronin T, McNally N, et al. A transgenic mouse model for gene therapy of rhodopsin-linked Retinitis Pigmentosa. Vision Res. 2008;48(3):386-91.
25. O'Reilly M, Palfi A, Chadderton N, Milligton-Ward S, Ader M, Cronin T, et al. RNA interference-mediated suppression and replacement of human rhodopsin in vivo. Am J Hum Genet. 2007;81(1):127-35.
26. Weleber RG. Inherited and orphan retinal diseases: phenotypes, genotypes, and probable treatment groups. Retina. 2005;25(8 Suppl):S 4-S7.
27. Côco M, Baba NT, Sallum JM. Avaliação da autofluorescência do fundo de olho nas distrofias de retina com o aparelho Heidelberg Retina Angiograph2. Arq Bras Oftalmol. 2007;70(5):739-45.
28. Kong J, Kim SR, Binley K, Pata I, Doi K, Mannik J, et al. Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy. Invest Ophthalmol Vis Sci. 2005:46:E-Abstract 5210.
29. Allocca M, Doria M, Petrillo M, Colella P, Garcia-Hoyos M, Gibbs D, et al. Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice. J Clin Invest. 2008;118(5):1955-64.
30. Liarth JC, Gonçalves EA, Gonçalves JO, Neiva DM, Leal FA. Síndrome de Usher: caracteristicas clínicas. Arq Bras Oftalmol. 2002;65(4):457-61.
31. Williams DS. Usher syndrome: animal models, retinal function of Usher proteins, and prospects for gene therapy. Vision Res. 2008;43(3):433-41.
32. Gibbs D, Kitamoto J, Williams DS. Abnormal phagocytosis by retinal pigmented epithelium that lacks myosin VIIa, the Usher syndrome 1B protein. Proc Natl Acad Sci USA. 2003;100(11):6481-6.
33. Hashimoto T, Gibbs D, Lillo C, Azarian SM, Legacki E, Zhang XM., et al. Lentiviral gene replacement therapy of retinas in a mouse model for Usher syndrome type 1B. Gene Ther. 2007;14(7):584-94.
34. Le Meuer G, Stieger K, Smith AJ, Weber M, Deschamps JY, Nivard D, et al. Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium. Gene Ther. 2007;14(4):292-303.
35. Narfström K, Katz ML, Ford M, Redmond TM, Rakoczy E, Bragadóttir R. In vivo gene therapy in young and adult RPE65-/- dogs produces long-term visual improvement. J Hered. 2003:94(1):317.
36. Acland GM, Aguirre GD, Ray J, Zhang Q, Aleman TS, Cideciyan AV, et al. Gene therapy restores vision in a canine model of childhood blindness. Nat. Genet. 2001;28(1):92-5.
37. Van Hooser JP, Aleman TS, He YG, Cideciyan AV, Kuksa V, Pittler SJ, et al. Rapid restoration of visual pigment and function with oral retinoid in a mouse model of childhood blindness. Proc Natl Acad Sci USA. 2000;97(15):8623-8.
38. Bainbridge JW, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K, et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med. 2008;358(21):2231-9. Comment in: N Engl J Med. 2008;358(21): 2282-4.
39. Maguire AM, Simonelli F, Pierce EA, Pugh EN Jr, Mingozzi F, Bennicellli J, et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 2008;358(21):2240-8. Comment in: N Engl J Med. 2008;358(21):2282-4.